Профили пользователей по запросу "Raghav Sundar"

Raghav Sundar

Yale University
Подтвержден адрес электронной почты в домене yale.edu
Цитируется: 4866

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

…, SH Tay, CB Teo, BKJ Tan, YH Chan, R Sundar… - Bmj, 2022 - bmj.com
Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Biomarkers for homologous recombination deficiency in cancer

MM Hoppe, R Sundar, DSP Tan… - JNCI: Journal of the …, 2018 - academic.oup.com
Defective DNA repair is a common hallmark of cancer. Homologous recombination is a
DNA repair pathway of clinical interest due to the sensitivity of homologous recombination-…

Low programmed death-ligand 1–expressing subgroup outcomes of first-line immune checkpoint inhibitors in gastric or esophageal adenocarcinoma

…, NL Syn, EC Smyth, YY Soon, R Sundar - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The US Food and Drug Administration has granted regulatory approval for the
use of nivolumab—an immune checkpoint inhibitor (ICI)—in the first-line treatment of …

Nivolumab in NSCLC: latest evidence and clinical potential

R Sundar, BC Cho, JR Brahmer… - … advances in medical …, 2015 - journals.sagepub.com
New insight on the interaction between the immune system and tumor has identified the
programmed death-1/programmed death-1 ligand pathway to be a key player in evading host …

Combining DNA damaging therapeutics with immunotherapy: more haste, less speed

JS Brown, R Sundar, J Lopez - British journal of cancer, 2018 - nature.com
The idea that chemotherapy can be used in combination with immunotherapy may seem
somewhat counterproductive, as it can theoretically eliminate the immune cells needed for …

Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer

V Kumar, K Ramnarayanan, R Sundar… - Cancer discovery, 2022 - AACR
We profiled gastric malignancies at single-cell resolution and identified increased plasma
cell proportions as a novel feature of diffuse-type tumors. We also uncovered distinct cancer-…

[HTML][HTML] Front of pack labels enhance attention to nutrition information in novel and commercial brands

MW Becker, NM Bello, RP Sundar, C Peltier, L Bix - Food policy, 2015 - Elsevier
Objectives (1) To assess whether Front-of-Pack (FOP) nutrition labels garner attention more
readily than more complete, mandated nutrition information (the Nutrition Facts Panel (NFP), …

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort …

…, LKP Suen, CW Chan, J Yorke, C Farrell, R Sundar - BMC cancer, 2019 - Springer
Background There are inconsistencies in the literature regarding the prevalence and
assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored CIPN …

Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy

…, QH Miow, LH Loo, WP Yong, R Sundar - Gastric Cancer, 2022 - Springer
Background Immune checkpoint inhibitors (ICI) are now standard-of-care treatment for
patients with metastatic gastric cancer (GC). To guide patient selection for ICI therapy, …

Immunotherapy in the treatment of non-small cell lung cancer

R Sundar, R Soong, BC Cho, JR Brahmer, RA Soo - Lung Cancer, 2014 - Elsevier
Advances in the understanding of the role of the immune system in tumor immunosurveillance
have resulted in the recognition that tumors can evade immune destruction via the …